Tone Nygaard Flølo1,2, John R Andersen3, Ronette L Kolotkin3,4, Anny Aasprang3, Gerd K Natvig5, Karl O Hufthammer6, Villy Våge7,8. 1. Department of Surgery, Voss Hospital, Haukeland University Hospital/The Western Norway Health Region Authority, Sjukehusvegen 16, 5704, Voss, Norway. tone.flolo@helse-bergen.no. 2. Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. tone.flolo@helse-bergen.no. 3. Department of Surgery, Førde Hospital Trust/Western Norway University of Applied Sciences, Førde, Norway. 4. Department of Community and Family Medicine, Duke University School of Medicine, Durham, NC, USA. 5. Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. 6. Competence Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway. 7. Department of Surgery, Voss Hospital, Haukeland University Hospital/The Western Norway Health Region Authority, Sjukehusvegen 16, 5704, Voss, Norway. 8. Scandinavian Obesity Surgery Registry (SOReg-N), Haukeland University Hospital/Voss Hospital, Bergen, Norway.
Abstract
BACKGROUND: We present 5-year outcomes after vertical sleeve gastrectomy (VSG), including complications and revisions, weight change, obesity-related diseases and health-related quality of life (HRQOL). METHODS: Patients operated from December 2005 to November 2010 were included. All variables except HRQOL (obtained using Short Form-36) were assessed prospectively. HRQOL data was assessed cross-sectionally, comparing 5-year results to both a baseline cohort of severely obese patients prior to bariatric surgery and to Norwegian norms. RESULTS: Of 168 operated patients (mean age, 40.3 ± 10.5 years; 71% females), 92% completed 2-year and 82% 5-year follow-up. Re-intervention for complications occurred in four patients, whereas revision surgery was performed in six patients for weight regain and in one patient for gastroesophageal reflux disease (GERD). Mean body mass index (BMI) decreased from 46.2 ± 6.4 kg/m2 at baseline to 30.5 ± 5.8 kg/m2 at 2 years and 32.9 ± 6.1 kg/m2 at 5 years. Remission of type 2 diabetes mellitus (T2DM) and hypertension occurred in 79 and 62% at 2 years, and 63 and 60% at 5 years, respectively. The percentage of patients treated for GERD increased from 12% preoperatively to 29% at 2 years and 35% at 5 years. The physical and mental SF-36 summary scores showed significantly better HRQOL at 5 years compared with the baseline cohort, but did not reach population norms. CONCLUSION: The majority of VSG patients maintained successful weight loss and improvement of T2DM, hypertension and HRQOL at 5 years. Preventing weight regain and GERD are important considerations with this procedure.
BACKGROUND: We present 5-year outcomes after vertical sleeve gastrectomy (VSG), including complications and revisions, weight change, obesity-related diseases and health-related quality of life (HRQOL). METHODS:Patients operated from December 2005 to November 2010 were included. All variables except HRQOL (obtained using Short Form-36) were assessed prospectively. HRQOL data was assessed cross-sectionally, comparing 5-year results to both a baseline cohort of severely obesepatients prior to bariatric surgery and to Norwegian norms. RESULTS: Of 168 operated patients (mean age, 40.3 ± 10.5 years; 71% females), 92% completed 2-year and 82% 5-year follow-up. Re-intervention for complications occurred in four patients, whereas revision surgery was performed in six patients for weight regain and in one patient for gastroesophageal reflux disease (GERD). Mean body mass index (BMI) decreased from 46.2 ± 6.4 kg/m2 at baseline to 30.5 ± 5.8 kg/m2 at 2 years and 32.9 ± 6.1 kg/m2 at 5 years. Remission of type 2 diabetes mellitus (T2DM) and hypertension occurred in 79 and 62% at 2 years, and 63 and 60% at 5 years, respectively. The percentage of patients treated for GERD increased from 12% preoperatively to 29% at 2 years and 35% at 5 years. The physical and mental SF-36 summary scores showed significantly better HRQOL at 5 years compared with the baseline cohort, but did not reach population norms. CONCLUSION: The majority of VSG patients maintained successful weight loss and improvement of T2DM, hypertension and HRQOL at 5 years. Preventing weight regain and GERD are important considerations with this procedure.
Entities:
Keywords:
Comorbidities; Health-related quality of life; Vertical sleeve gastrectomy; Weight loss
Authors: Villy Våge; Roy M Nilsen; Arnold Berstad; Jan Behme; Nils Sletteskog; Ronny Gåsdal; Camilla Laukeland; Gunnar Mellgren Journal: Obes Surg Date: 2013-01 Impact factor: 4.129
Authors: Gitanjali M Singh; Goodarz Danaei; Farshad Farzadfar; Gretchen A Stevens; Mark Woodward; David Wormser; Stephen Kaptoge; Gary Whitlock; Qing Qiao; Sarah Lewington; Emanuele Di Angelantonio; Stephen Vander Hoorn; Carlene M M Lawes; Mohammed K Ali; Dariush Mozaffarian; Majid Ezzati Journal: PLoS One Date: 2013-07-30 Impact factor: 3.240
Authors: Maria S Altieri; Jie Yang; Donald Groves; Nabeel Obeid; Jihye Park; Mark Talamini; Aurora Pryor Journal: Surg Endosc Date: 2017-08-24 Impact factor: 4.584
Authors: Tone Nygaard Flølo; Grethe S Tell; Ronette L Kolotkin; Anny Aasprang; Tone Merete Norekvål; Villy Våge; Karl Ove Hufthammer; John Roger Andersen Journal: BMJ Open Date: 2019-09-12 Impact factor: 2.692